Search PubMed⌕ Search

Biomedical subjects

H Dralle

Publications and source records attributed to H Dralle.

At least 199 records · Page 11Linked to original sources

[Histology, immunocytochemistry and DNA cytophotometry of adrenal glandpheochromocytoma (PCC)--a morphologic clinal study of 64 tumors].

Surgical specimens of 64 adrenal PCCs were investigated by conventional histology, immunocytochemistry and DNA-cytophotometry. Tumour weights of more than 200 g were recorded for each of the 6 malignant, but for only one of the 58 clinically benign neoplasms. Increased mitotic activity (greater than 5 mitoses/10 HPF) was, apart from one benign lesion, only seen among malignomas. Immunocytochemically, all malignomas were entirely devoid of S100-positive sustentacular cells and, as compared to benign PCCs, showed reduced expression rates of different neuropeptides. Upon cytophotometry, only 5/43 tumours exhibited euploid DNA histograms, all these cases belonging to the group of benign PCC. According to these findings, morphology does not enable a definite prediction of the clinical course of individual PCC cases, but renders the definition of risk groups possible. A benign diagnosis can be made in multihormonal euploid tumours weighing less than 200 g. In larger neoplasms and in cases lacking sustentacular cells and showing increased mitotic activity, an unfavourable prognosis is to be suspected and the same therapeutic procedures should be applied as for tumours in which malignancy is evident in metastatic growth.

Adrenal Gland Neoplasms↗

[The importance of high-dose alpha-receptor blockade for blood volume and hemodynamics in pheochromocytoma].

This prospective clinical study evaluates the possible beneficial effects of increased phenoxybenzamine dosage in the preoperative treatment of patients with pheochromocytoma. For this purpose total blood volume (TBV) prior to and after treatment with phenoxybenzamine and hemodynamic changes during surgery were determined in two groups of patients: group I (n = 12) received a mean dosage of 140 mg, group II (n = 12) 270 mg/day. The mean TBV in group I showed no changes after treatment with phenoxybenzamine, while the TBV in group II increased by 5.6 ml/kg body weight, corresponding to an increase in plasma volume (PV) of 10.2%. These changes were not significant, however. The intraoperative vasodilator requirement for the treatment of catecholamine induced hypertension during tumor manipulation was significantly less for group II: total nitroprusside administration averaged 8.7 mg in group I and 0.8 mg in group II (P less than 0.0005). Patients in group I received a total of 2.6 mg nitroglycerin compared with only 0.5 mg for patients in group II (P less than 0.005). In conclusion, preoperative treatment of patients with pheochromocytoma with increased dosages of phenoxybenzamine is beneficial to intraoperative management by decreasing hemodynamic instability due to tumor manipulation and following resection. This treatment was effective for preventing complications such as excessive tachycardia, cardiac arrhythmias, hypertensive crises, or left ventricular failure.

Adrenal Gland Neoplasms↗

[Undifferentiated thyroid cancer: improved therapeutic results following initial radical intervention and early postoperative radiotherapy].

During a 16-year period (1972-1988), 40 out of 477 thyroid cancer patients underwent thyroidectomy for undifferentiated thyroid carcinoma. To analyse the significance of "radical" versus "palliative" surgical procedures with regard to early postoperative course, operative complications and survival, all patients records were reviewed and actually followed up. A significant better survival was correlated with radical (n = 17) versus palliative tumor resection (n = 23) (p less than 0.001), and total thyroidectomy (n = 22) versus subtotal thyroidectomy (n = 18) (p less than 0.006). Radical surgery with early postoperative external irradiation revealed no postoperative mortality and only one symptomatic cervical tumor recurrence. In contrast, palliative surgery, particularly in the case of synchronous tracheotomy, was attended with a relatively high mortality (30%) and symptomatic local recurrences. The results of this study suggest that in undifferentiated thyroid carcinoma without infiltration of the esophageal or tracheal mucosa an attempt of radical tumor resection should be undertaken, since palliative surgical procedures revealed a significantly lower survival due to complications of persistent or recurrent cervical tumor infiltration and frequently were accompanied by local complications during the postoperative course.

Aged↗

Amyloid goiter and arthritides after kidney transplantation in a patient with systemic amyloidosis and Muckle-Wells syndrome.

A case of hereditary AA amyloidosis with Muckle-Wells syndrome is described. After a successful kidney transplantation for chronic renal failure due to renal amyloid deposits at age 21, the patient, a white female now 26 years of age, developed a large amyloid goiter as a manifestation of the systemic amyloidosis and recurrent monarthritides. Both observations are novel for this disease. Subtotal thyroidectomy and oral colchicine administration, known to be effective in preventing complications of familial Mediterranean fever, another hereditary type of AA amyloidosis, proved highly effective in the management of this unusual case.

Adult↗

A young woman with pituitary-tumor, Cushing's syndrome and medullary thyroid carcinoma--a rare case of MEN II?

A young woman presented with Cushing's syndrome. As a repeat surgical resection of a pituitary tumor did not cure her a bilateral adrenalectomy was performed, which resulted in symptomatic improvement of the patients condition. Several months later, a medullary carcinoma of the thyroid (MTC) was detected and resected. Retrospective analysis suggests that a paraneoplastic Cushing's syndrome may have been present in this patient. A connection of the pituitary tumor and the MTC could not be proved, a MEN-II-syndrome does not seem likely.

Adult↗

Screening for pheochromocytoma in the MEN 2 syndrome.

Twenty-two patients with the multiple endocrine neoplasia type 2 (MEN 2) syndrome were screened for pheochromocytoma since it is a major cause of morbidity in MEN 2 families. Clinical symptoms, biochemical parameters, ultrasound, computed tomography or magnetic resonance imaging, and meta-iodo-benzylguanidine (MIBG) scintigraphy were evaluated for detection of adrenal tumors. Clinical symptoms and plasma or urine catecholamines appeared to be nonspecific, whereas MIBG scintigraphy was highly specific and the most sensitive parameter. Patients older than age 30 should be scintigraphically screened at least once despite the radiation exposure. Demonstration of only slight uptake is not an indication for surgery but rather for careful follow-up.

3-Iodobenzylguanidine↗

Adrenal cortex transplantation after bilateral total adrenalectomy in the rat.

An experimental animal model with adrenal cortex transplantation was developed to study adrenal cortex replacement therapy in patients with multiple endocrine neoplasia type 2 who have had bilateral adrenalectomy for pheochromocytomas. Adrenal cortex of syngenetic rats was isolated from the medulla by collagenase digestion and a defined sedimentation. The cell suspension of the cortical cells was implanted under the kidney capsule of untreated syngenetic rats. After two weeks the recipients were bilaterally adrenalectomized. Serum corticosterone levels were measured as an estimate of function of the grafts. All recipients were healthy throughout the observation period, whereas all adrenalectomized controls died within 18 days. Vital cortex cells could be demonstrated in the explanted grafts by immunohistochemistry. Corticosterone levels of transplanted animals were nearly normal (9.5 ng/100 mL +/- 0.4) compared to the controls (0.20 ng/mL +/- 0.06). This animal model of adrenal cortex transplantation allows the separation of medullary from cortical cells. After transplantation, these cortical cells survived for eight weeks and were able to replace the adrenal cortex function.

Adrenal Cortex↗

DNA cytophotometric findings in pheochromocytoma.

Fifty adrenalectomy specimens containing normal (n = 3), hyperplastic (n = 4), or neoplastic (n = 43) medullary tissue were subjected to quantitative measurements of DNA content. Of the 43 pheochromocytomas, 16 were neoplasms inherited in the setting of multiple endocrine neoplasia type 2A. Five of 27 sporadic pheochromocytomas followed a malignant clinical course. Follow-up data were available in 25 patients. In normal medulla and adrenomedullary hyperplasia either diploid or euploid DNA distributions were found. In contrast, 87% (33 of 38) of the benign and all five malignant pheochromocytomas exhibited nondiploid or aneuploid DNA histograms. No differences in DNA content existed between sporadic and hereditary tumors. In contrast to earlier reports, in this study DNA cytophotometry was not suitable to discriminate benign from malignant adrenomedullary tumors. In addition, DNA measurements appeared not to be a useful tool to assess the prognosis of an individual malignant pheochromocytoma.

Adolescent↗

[Immunohistology and prognosis in thyroid cancer. Determination of the malignancy potential of papillary and medullary neoplasms by the detection of S-100 protein and Leu-M1 antigen].

170 thyroid carcinomas were investigated for the presence of S-100-protein-positive Langerhans cells (LC) and the expression of Leu-M1-antigen. Dense LC infiltrates were found only in papillary tumours and were shown to be significantly related to prognosis. Irrespective of any other feature, no single instance of death resulting from cancer occurred among 23 tumours (including 6 cases of stage pT4) with dense infiltrates (greater than 20 LC/unit field) while 9/53 (17%) of the remaining patients died from carcinoma (p less than 0.01). The degree of epithelial Leu-M1 expression was significantly related to the biological behaviour of papillary and medullary neoplasms. Death resulting from cancer occurred 17 times more frequently among papillary tumours with marked positivity (greater than 15%) as compared to cases with slight or absent immunoreactivity (8/24 vs. 1/52; p less than 0.00005). Among medullary carcinomas, local recurrences occurred 2.9 times (14/16 vs. 7/23; p less than 0.005) and death resulting from tumour occurred 4.3 times (9/16 vs. 3/23; p less than 0.03) more frequently for intensely stained as compared to slightly immunoreactive and unstained neoplasms.

Antigens, Differentiation, Myelomonocytic↗

Prognostic factors in medullary thyroid carcinomas.

Among 45 patients with medullary thyroid carcinoma, clinical parameters (age, sex, stage) and morphological findings (histological and immunocytochemical pattern, DNA content) were correlated with follow-up data. Prognosis was found not to be related to histological features or to immunoreactivity for a variety of hormonal and nonhormonal products typical of neoplastic C-cells. Instead, survival was significantly correlated to age, sex and stage of disease. The best prognosis was seen in women less than 40 years of age and revealing an early stage of disease. In addition, DNA parameters and the degree of aberrant epithelial Leu-M1 expression appeared to correspond to the outcome of disease in the majority of cases. A benign clinical course was twice as frequent among tumours of normal diploid DNA value compared to carcinomas of higher DNA content. Irrespective of other morphological and clinical features, local recurrences occurred 3 times and death resulting from tumour occurred 4.5 times more frequently among cases with marked Leu-M1 positivity in comparison to tumours with only slight or absent reactivity.

Carcinoma↗

Surgical aspects of familial pheochromocytoma.

During a 15-year-period (1973-1987), 13 patients with familial pheochromocytoma (PCC) underwent unilateral (n = 7) or bilateral (n = 6) total adrenalectomy without major operative morbidity (1 incidental splenectomy in 8 left-side adrenalectomies) and no mortality. 1 patient died 3 years after unilateral adrenalectomy from unrelated cause. The remaining patients were followed up for a mean time of 5.2 years and could be traced and investigated. 3 patients have been adrenalectomised on the contralateral side because of PCC 5, 6 and 10 years after unilateral adrenalectomy. No patient had metastatic PCC. 1 patient sustained recurrent Addisonian crises after bilateral total adrenalectomy. 1 patient developed recurrent hypertension after bilateral adrenalectomy, but without evidence of recurrent disease. In 3 patients bilateral total adrenalectomy with adrenal cortex autotransplantation was performed, however, complete hormone supplementation therapy had to be continued because of autograft functional insufficiency. In considering the number of patients in this study, who only needed a unilateral adrenalectomy in familial PCC, the more pragmatic surgical approach to familial PCC seems to be supported. Bilateral total adrenalectomy with adrenal cortex autotransplantation was not as effective functionally as supposed by histological examination of transplant biopsy.

Adolescent↗

Leu-M1 immunoreactivity and prognosis in medullary carcinomas of the thyroid gland.

Leu-M1 antigen is a monocyte/granulocyte-related marker known to be consistently expressed in the Reed-Sternberg cells of patients with Hodgkin's disease and to be present in tumour cells of a variety of non-haematopoietic neoplasms, most of them adenocarcinomas. The biological significance of this aberrant reaction has not yet been clarified. Recently, however, we have demonstrated that marked epithelial Leu-M1 immunoreactivity significantly correlated with an unfavourable clinical course in papillary carcinomas of the thyroid gland. The findings of the present study obtained from surgical specimens of 39 tumours suggest that Leu-M1 immunostaining also provides significant prognostic information in patients with medullary carcinoma (MC) of this organ. Irrespective of other morphological and clinical features, local recurrences occurred 2.9 times (P less than 0.005) and death resulting from tumour occurred 4.3 times (P less than 0.03) more frequently among MCs with marked Leu-M1 positivity (greater than 15% tumour cells positively stained) in comparison to tumours with only slight or absent immunoreactivity. A significantly higher recurrence rate of intense Leu-M1-positive MCs was even evident when comparing only tumours of stage pT1-3N0M0 (P less than 0.005). Our findings infer that Leu-M1 immunostaining might be of clinical relevance to the selection of different aggressive adjuvant therapeutic procedures to be used in MCs with high or low malignant potential.

Antigens, Differentiation, T-Lymphocyte↗

[Surgical therapy of sporadic and familial pheochromocytoma].

From 1975 through 1987, 54 patients underwent operations for pheochromocytoma (PCC): 37 patients for sporadic unilateral adrenal PCC, 9 for bilateral and familial PCC, and 4 patients for paraganglioma. In 4 additional patients, laparotomy failed to discover the reason for hypercatecholaminemia. There were no operative mortality and a low morbidity for unilateral (n = 43) as well as for bilateral adrenalectomy (n = 6). To avoid hormone replacement therapy after bilateral total adrenalectomy at least for some years, unilateral instead of bilateral adrenalectomy was preferred to be the initial surgical procedure of choice for familial and MEN-IIA-associated unilateral adrenal PCC. Autologous transplantation of the adrenal cortex were performed in 2 patients after bilateral adrenalectomy. 6 months postoperatively, the transplants were vital as proved by light-microscopy, but sufficiently functioning only in 1 patient.

Adolescent↗

[Preoperative diagnosis of suspected pheochromocytoma--retrospective assessment of diagnostic criteria].

A retrospective analysis of clinical laboratory and imaging diagnostic criteria of pheochromocytoma was performed over a period of 2 years in 80 patients (17 with surgically proven pheochromocytomas) and yielded the following results: Clinical symptoms are not very characteristic and do not allow the diagnosis. The best diagnostic criterian was the determination of the excretion of norepinephrine and especially of epinephrine in repeated urine samples (90% correct positive, 5% false positive). The diagnostic value of plasma catecholamine concentrations is less because of a wide scatter in both, healthy subjects and patients with pheochromocytoma. The determination of dopamin as well as the clonidintest do not seem to be helpful in the diagnosis. More than 90% of our pheochromocytomas are detected by sonography or computer tomography. The MiBG scans seem to be helpful with, however, some false negative cares.

Adrenal Gland Neoplasms↗